semaglutide weight loss fda approval US approves drug Wegovy to prevent cardiovascular events Wegovy weight-loss medication gets FDA

Tuesdays approval is backed by data from a Phase III trial comprising around 400 patients with a history of bipolar I disorder who are currently suffering from a manic episode

Special considerations for chronic fatigue syndrome and post-viral fatigue Chronic fatigue syndrome (CFS), is a complex condition that causes extreme fatigue that doesnt improve with rest

In the SUSTAIN trial, 52% of patients receiving semaglutide experienc ed gastrointestinal side effects, compared with 35% in the placebo group

Preservation over Panicking: If IUI doesnt work after 3 tries, we pivot to IVF/ICSInot just for the current pregnancy, but to bank embryos for the future